Background-Poststenotic dilatation (PSD) occurs in a low-pressure region where recirculation eddies oscillate in size during the cardiac cycle. NO may be an important mediator of PSD. Methods and Results-Femoral arteries of 7 adult male New Zealand White rabbits were stenosed bilaterally to achieve a diameter reduction of 70.9Ϯ6.7% (nϭ14). At the time of stenosis, the adventitia of one of the arteries was coated with 1 mmol/L of N G -nitro-L-arginine methyl ester (L-NAME) in 22% (wt/vol) Pluronic gel, while the contralateral vessel was coated with gel without L-NAME. In stenosed femoral arteries that were treated with gel without L-NAME, a maximum PSD of 30.99Ϯ7.92% (nϭ7) was observed in polymer casts at 3 days relative to the mean proximal diameter of 1.57Ϯ0.25 mm at a position 12 mm upstream of each stenosis. In contrast, the vessels treated with L-NAME exhibited a maximum PSD of only 7.16Ϯ8.81% (nϭ7) relative to the mean proximal diameter of 1.55Ϯ0.16 mm. L-NAME caused a 76.9% reduction (PϽ0.001, nϭ7) of PSD. Similarly, N G -monomethyl-L-arginine 1 mmol/L and N G -nitro-Larginine 10 mol/L attenuated PSD by 57.5% (PϽ0.001, nϭ6) and 63.9% (PϽ0.05, nϭ6), respectively. Indomethacin 10 mol/L caused no reduction in PSD. Arterial rings obtained from the poststenotic region were more sensitive and responsive to acetylcholine than those obtained proximal to the stenosis. Conclusions-NO, but not prostacyclin, is a major mediator of PSD.
T he pronounced dilatation of vessels distal to a stenosis is a dramatic response of vessel and vascular cell function to hemodynamic forces. The earliest descriptions of poststenotic dilatation (PSD) date back to 1842 1 and 1845 (as cited in References 2 and 3), but the mechanisms and mediators of the process are still unknown. As reviewed by Roach, 4 aneurysms associated with PSD can occur in humans in regions distal to the coarctation of the aorta, abdominal aorta, and pulmonary arteries. Atherosclerotic plaques of the renal, carotid, and femoral arteries can cause PSD, as can compression of arteries by abnormal anatomy of bones, muscle, or ligaments. PSD can be generated experimentally in rabbit carotid and thoracic arteries 5, 6 and canine femoral and carotid arteries 4 and is reversible after removal of the stenosis. 7 Fenestration and fragmentation of the internal elastic lamina increase distal to a stenosis 8, 9 within 10 days of vessel stenosis. Degenerative changes during PSD include a decrease in smooth muscle cell number density and elastin content and an increase in collagen 6 and collagenase activity. 10 The studies by Roach 4 and others in the 1960s can be viewed in the context of the well-established endothelial response to hemodynamic forces (for review, see References 11 and 12). Fluid shear stress enhances, within seconds, endothelial production of NO and prostacyclin, [13] [14] [15] both of which are relatively short-lived species that act locally. Exposure to arterial shear stresses elevates endothelial NO synthase (eNOS) mRNA and protein 16, 17 within a few hours and suppresses endothelin gene expression in cultured endothelium. 18, 19 The NO production and eNOS mRNA levels are elevated during the stretching of endothelial cells, 20 as is endothelin production. 21 Yet, these studies do not fully explain the occurrence of PSD, because the region distal to the stenosis is a site of low pressure and complex hemodynamics where recirculation eddies oscillate in size as the flow reattachment point moves back and forth during the cardiac cycle. [22] [23] [24] Turbulence-induced vibration had been hypothesized to cause PSD, because isolated human iliac arteries dilate when vibrated via a loudspeaker. 2 However, Gow et al 25 showed that mechanical vibration of rabbit thoracic aorta in vivo does not cause vasodilation. In addition, Ojha and Langille 26 conducted extensive flow visualization of model stenosed rabbit carotids and found that PSD can occur with stenoses from 50% to 60% diameter reduction in the carotid arteries, whereas no transition to turbulence is observed in corre-sponding flow models. In flow models of more severe carotid stenoses of 70% diameter reduction, a very localized transition to turbulence was identified (6 to 8 tube diameters downstream) during the early deceleration phase of the cardiac cycle. 26 However, this position of helical flow and vortex shedding (a transition to turbulence) did not correlate with the position of maximal PSD. These studies indicate that turbulence is not strictly required for the development of PSD.
Locally elevated capacity of the vessel wall to produce and/or respond to NO may be the cause of PSD and represents a response to the complex hemodynamics within the poststenotic recirculating vortex. Our study investigated pharmacological antagonism of NO production at the site of a stenosis to modulate the progression of PSD. The stenoses of 70% reduction in diameter used in this study are not associated with turbulence and create a modest reduction in flow associated with vasoconstriction proximal to the stenosis. 27 
Methods

Animal Surgery
Male New Zealand White rabbits (2.1Ϯ0.3 kg) were anesthetized with ketamine (30 to 40 mg/kg IM) and xylazine (5 to 8 mg/kg IM). The femoral arteries were exposed distal to the hip joint and carefully isolated from the femoral vein and sciatic nerve. A well-defined stenosis was produced on the left and right arteries according to the methods of Langille et al 28 by use of a 4-0 Tevdek (polyester fiber, nonabsorbable) suture tied snugly around the vessel and the shaft of a 25-gauge hypodermic needle (OD, 0.51 mm). The needle shaft was then removed. The L-arginine analogue N G -nitro-L-arginine methyl ester (L-NAME) (Research Biochemicals International) was added after stenosis by coating the adventitia of one of the exposed femoral arteries with 1 mL of a sterile suspension of 1.0 mmol/L L-NAME in 22.5% (wt/vol) of F-127 Pluronic gel (Molecular Probes, Inc) diluted in sterile PBS. The contralateral femoral artery was treated with 1 mL of a sterile suspension of 22.5% (wt/vol) of F-127 Pluronic gel alone. In some experiments,
indomethacin 10 mol/L was in the gel. In experiments using unilateral stenosis without Pluronic gel, we observed that the gel was not required for the development of PSD. Placement of a sterile 2-mm transit-time ultrasonic probe (Transonics Systems, Inc) before and after the placement of the stenosis allowed measurement of volumetric flow rate (mL/min) through the femoral vessels. Timeaveraged flows through rabbit femoral artery were Ϸ10 mL/min before stenosis. After placement of the suture, the stenoses caused an Ϸ30% reduction in mean flow (Figure 1 ). Rabbits were given Crystiben (sterile penicillin G benzathine and penicillin G procaine in aqueous suspension; 300 000 IU/mL) on the day of surgery (1 mL) and every 48 hours afterward. All surgeries were performed in the School of Medicine, Laboratory Animal Facility, at SUNY-Buffalo under approval by the Internal Review Board.
Polymer Casting and Diameter Analysis
At 3 days after surgery, the rabbits were anesthetized by injection of 30 mg/kg sodium pentobarbital IV through the marginal ear vein. The midabdominal aorta was catheterized and perfused with a warm saline solution (37°C) followed by a methyl methacrylate casting compound (Batson's No. 17 corrosion casting compound, Polysciences Inc) under a constant pressure of 100 mm Hg, according to the methods of Langille 27, 28 and Levesque. 29 After the compound had set for 24 hours, the abdominal aorta and the femoral branches were dissected as a unit. The remaining tissue was removed by immersion of the cast into 25% NaOH at 50°C for 12 hours. Diameters along the vessel cast were measured by calibrated light microscopy with NIH Image 1.54 software (pixel resolution of 
Similarly, the maximum percent PSD (max % PSD) was calculated for the maximum distal diameter (Distal distal max ) relative to the diameter (D prox ) at 12.0 mm proximal to the stenosis by Equation 2: 
The mean value of the max % PSD of casts (determined by Equation 2) does not necessarily correspond to the % PSD observed in averaged aligned cast diameter data sets because the exact position of maximal PSD of each cast varied slightly.
Computational Fluid Dynamics
The velocity field and mean wall shear stress for cast geometries were obtained by Galerkin finite-element method (FIDAP 7.0, Fluid Dynamics International) solution of the Navier-Stokes equation for steady, laminar flow of a Newtonian fluid equivalent to blood (viscosity, 0.035 poise) through the 2-dimensional axisymmetric cast geometry as described by Strony et al. 31 Assuming blood to behave as a Newtonian fluid results in wall shear stresses that have been shown to be accurate to Ϸ10% compared with a more complex constitutive equation for shear thinning behavior. 31 Meshes were refined to Ͼ14 500 quadrilateral elements, with increased mesh resolution at the stenosis and near the wall to eliminate spurious numerical oscillations in the velocity field. Fully developed parabolic flow was used as the inlet condition, corresponding to a mean volumetric flow of 7 mL/min (as observed experimentally in Figure  1 , bottom), and the no-slip boundary condition was applied at the wall.
Vascular Ring Studies
For ring studies, the femoral arteries were dissected from anesthetized rabbits that had 3-day unilateral stenosis. The arteries were placed in room-temperature Krebs-Ringer solution (in mmol/L: NaCl 118, KCl 4.7, CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 25.5, glucose 5.6). Dissected arteries were cut into rings 2 to 3 mm wide (3 to 4 mg each), mounted on stainless steel hooks, and placed in water-jacketed organ baths maintained at 37°C as previously described. 32 Arteries were bathed in 6 mL of Krebs-Ringer solution aerated with a mixture of 94% O 2 and 6% CO 2 to obtain a pH of 7.4, a PCO 2 of 38 mm Hg, and a PO 2 Ͼ500 mm Hg. Continuous isometric force readings were obtained with a force-displacement transducer (Statham UC 2). All rings were allowed to equilibrate for 15 minutes in the Krebs-Ringer solution. Rings were then placed at their optimal length by repeated stretching in small increments over the next 20 minutes until resting tone remained stable at 0.8 g. This procedure places each vessel at its optimal length. 33 Rings were precontracted with an EC 50 concentration of the ␣ 1 -adrenergic receptor agonist phenylephrine. When the contraction had reached a plateau, acetylcholine 10 Ϫ8 to 3ϫ10 Ϫ5 mol/L was added to the bathing solution in a cumulative manner to induce endothelium-dependent vascular relaxation by activating NOS in the endothelium. Before exposure to phenylephrine, all tissues were incubated with 10 Ϫ6 mol/L propranolol for 5 minutes to prevent any potential stimulation of ␤-adrenergic receptors and with 10 Ϫ5 mol/L indomethacin to block production of prostaglandins. Data were expressed as meanϮSEM. Statistical comparisons for the vascular reactivity studies were performed on the concentration-response curves by use of ANOVA with Student-Newman-Keuls test for post hoc testing of multiple comparisons. The 50% inhibitory concentrations (IC 50 ) for acetylcholine inhibition of constriction were obtained from the concentration-response curves in a similar manner. Significance was accepted at a value of PϽ0.05. 
Results
After 3 days, the stenosis of the femoral artery without L-NAME caused a pronounced dilatation at positions distal to the stenosis, as seen in the polymer cast, which was blocked by adventitial application of L-NAME (Figure 2 ). In this experiment, oxygen delivery due to an arterial flow was quite large, and any putative hypoxic dilatation would be much less than the observed PSD. 34 Furthermore, in large arteries, L-NAME would not be expected to completely antagonize dilatation due to hypoxia, 35 because intrinsic mechanisms during hypoxia would predominate. 36 Histology of the vessel wall after 3 days of stenosis is consistent with proximal vasoconstriction ( Figure 3A ) and PSD ( Figure 3B ).
The average diameters for aligned casts of stenosed femoral arteries in the absence or presence of L-NAME after 3 days of bilateral stenosis are shown in Figure 4A . In geltreated femoral arteries (no L-NAME), the position of maximal PSD was 6.1Ϯ2.8 mm (nϭ7) distal to the stenosis, corresponding to Ϸ4 vessel diameters downstream of the stenosis. In each of the 7 rabbits, L-NAME treatment of one of the stenosed femoral arteries attenuated the development of a large PSD compared with the contralateral stenosed vessels (Table) . The average percent stenosis for the 14 stenoses was 70.9Ϯ6.7% (Table) . In gel-treated femoral arteries (no L-NAME), the max % PSD ranged from 17.9% to 39.7% (mean, 30.99Ϯ7.92% max % PSD, nϭ7) after 3 days for 71.7Ϯ7.01% stenosis (diameter reduction) of rabbit femoral artery. In contrast, L-NAME-treated femoral arteries displayed significantly less PSD, ranging from 0% to 25.0% max % PSD (mean, 7.16Ϯ8.81% max % PSD, nϭ7). Thus, 1 mmol/L of L-NAME caused a 76.9% reduction (PϽ0.001) in PSD. The mean diameter at a position of 12 mm proximal to the stenosis was 1.57Ϯ0.25 mm for gel-treated vessels, compared with 1.55Ϯ0.16 mm for L-NAME-treated vessels. Consistent with the observations in the rabbit and canine carotid artery during chronic decreased flow, 27, 37 we have observed proximal vasoconstriction (nϭ8) in formalin-fixed or polymer-casted rabbit femoral arteries that had a stenosis relative to unstenosed contralateral sham-operated controls (data not shown).
Computational fluid dynamic analysis of the average vessel geometries shown in Figure 4A was conducted at a mean steady flow rate of 7.0 mL/min (see Figure 1 ) through each geometry. The wall shear stress reached peak values of Ϸ600 to 700 dynes/cm 2 in the throat of the stenosis, as expected for converging flows. 31 A prominent poststenotic vortex was observed in the simulations. The time-averaged position of flow reattachment was predicted to occur at 7 mm and 5 mm distal to the stenosis for gel-treated and L-NAME-treated vessel geometries, respectively ( Figure 4B and 4C ). This predicted position of reattachment corresponded well with the position of max % PSD of 6.1Ϯ2.8 mm observed in the casts of the no-L-NAME group. The spatial wall shear stress gradient as determined by computational fluid dynamic analysis at the position of flow reattachment [(Ѩ w /Ѩx)| wϭ0 ] was ϩ29.7Ϯ0.3 and ϩ50.4Ϯ0.5 dynes ⅐ cm Ϫ2 ⅐ cm Ϫ1 in gel-treated and L-NAME-treated vessel geometries, respectively, suggesting that the PSD response caused a Ͼ40% reduction (PϽ0.001) of the time-averaged shear stress gradient at the site of flow reattachment. In both gel-and L-NAME-treated stenosed vessels, the mean wall shear stress at positions between the stenosis and the reattachment point were elevated to 15 to 25 dynes/cm 2 relative to the far upstream shear stress of Ϸ13 to 15 dynes/cm 2 . For 6 rabbits with bilateral stenosis with one of the stenosed femoral arteries treated with L-NMMA, the L-NMMA caused a 57.5% reduction (PϽ0.001, nϭ6) in PSD, from 27.3Ϯ5.6% to 11.6Ϯ3.1% average max % PSD ( Figure 5A ). For 6 rabbits with bilateral stenosis with one of the stenosed femoral arteries treated with L-NNA, the L-NNA caused a 63.9% reduction (nϭ6, PϽ0.05) in PSD, from 24.7Ϯ17.2% to 8.93Ϯ10.1% average max % PSD ( Figure 5B) .
A possibility exists that L-NAME may attenuate endothelial production of prostacyclin in the presence of flow 38 -40 or antagonize muscarinic receptors. 41 We used adventitial delivery of 10 mol/L indomethacin in Pluronic gel to inhibit cyclooxygenase activity in a stenosed vessel ( Figure 6A ). Indomethacin had no effect on the development of PSD. The average max % PSD for indomethacin-treated stenoses was 26.4Ϯ11.5% (nϭ5), compared with 23.6Ϯ9.5% (nϭ5) for contralateral stenoses without indomethacin treatment. When both L-NAME and indomethacin were applied adventitially to a stenosed femoral artery ( Figure 6B ), an 11.8Ϯ8.15% (nϭ5) average max % PSD occurred, whereas the contralateral stenosed vessel treated only with indomethacin displayed a 29.4Ϯ8.75% (nϭ5) average max % PSD. Thus, L-NAME caused a 59.9% reduction in the formation of PSD when both vessels were simultaneously treated with indomethacin.
Over all experiments, stenosis of rabbit femoral artery produced 26.9Ϯ10.6% max % PSD (nϭ24) that was dramatically and significantly reduced in the 19 stenosed vessels treated with L-arginine analogues (L-NAME, L-NMMA, or L-NNA) and additionally in the 5 vessels treated with L-NAME plus indomethacin but was not reduced in any of the 10 vessels treated with indomethacin alone (Figure 7) .
In control vessel rings and rings taken proximal (2 to 12 mm) and distal (2 to 12 mm) to the stenosis, acetylcholine at concentrations from 10 Ϫ8 to 3ϫ10 Ϫ6 mol/L caused relaxation (Figure 8 ) and at higher concentrations of Ͼ10 Ϫ5 mol/L caused mild contraction, by stimulating the muscarinic receptors on vascular smooth muscle cells.
In rings distal to the stenosis, 10
Ϫ6 mol/L acetylcholine was sufficient to produce nearly 90% of maximal vasorelaxation (nϭ8), which significantly exceeded (PϽ0.01) the 35% and 45% relaxations achieved in proximal rings (nϭ9) and control rings (nϭ6), respectively. The 50% inhibitory concentration (IC 50 ) from the acetylcholine dose-response curves in Figure 8 was left-shifted (PϽ0.05) for PSD segments (IC 50 ϭ87Ϯ19 nmol/L, nϭ8) compared with proximal rings (IC 50 ϭ256Ϯ60 nmol/L, nϭ9) or control rings (IC 50 ϭ324Ϯ96 nmol/L, nϭ6). In addition, the poststenotic segments displayed relaxations of greater magnitude (at all doses of acetylcholine) than proximal or control rings, consistent with elevated capacity to produce and/or respond to NO in the poststenotic region. Control and proximal vessel rings precontracted to their EC 50 with phenylephrine achieved similar tensions of 1015Ϯ262 g/g tissue (nϭ6) and 1480Ϯ204 g/g tissue (nϭ9), respectively (PϽ0.001). However, distal vessel rings exhibited a greater EC 50 tension of 1625Ϯ159 g/g tissue (PϽ0.05).
Discussion
We have shown that inhibition of NO production by L-arginine analogues significantly attenuated the develop- Proximal diameters were taken at a position of 12.0 mm upstream of the site of the stenosis. The average percent stenosis based on diameter for all arteries relative to their proximal diameters was 70.9Ϯ6.7% (nϭ14).
Demonstration of Prevention of PSD by Local Adventitial Administration of L-NAME 1 mmol/L Relative to Gel-Treated Stenosed Vessels Without L-NAME
*P value relative to mean value for gel-treated control vessel.
ment of PSD. To the best of our knowledge, this is the first report of pharmacological antagonism of PSD. Furthermore, the enhanced vascular reactivity of vessel rings to acetylcholine in the poststenotic region is consistent with an important role for endothelium-produced NO as a mediator of PSD. In the present study, large-scale turbulence throughout the flow field is not expected, because the upstream, time-averaged Reynolds numbers were Ͻ100, based on the mean velocity. Turbulence would be expected to occur in this geometry at a Reynolds number of 300 to 400. 42 In light of several reports [12] [13] [14] 16, 17 of steady unidirectional laminar shear stress inducing NO production and elevating eNOS gene expression levels in cultured endothelial cells, elevated wall shear stress or rapid changes in direction and magnitude of wall shear stress are the likely initiators of PSD. This linkage was suggested in earlier experimental studies by Ojha et al. 43 Placement of a long stenosis (Ͼ4 mm) in conjunction with a thrombogenic stimulus (thrombin, endothelial denudation, or electric current) has been a model for thrombosis. 44 The short length (Ͻ1 mm) of the stenosis in the present study was not sufficient for shear-induced platelet activation or arterial thrombosis. 31 We have not observed thrombosis at the site of the stenosis or proximal or distal to the stenosis even out to 14 days. The vascular casts also provided no indication of thrombosis, because filling defects were never observed. Langille et al 28 observed extremely low endothelial replication rates downstream of the stenosis during the first week after placement of the stenosis. Furthermore, they observed (by scanning electron microscopy) no indication of injury or denudation of the endothelium at or near the coarctation. Importantly, removal of endothelium is generally associated with vasoconstriction, 45 not vasodilation, through the loss of basal endothelial NO production as well as platelet adhesion and consequent release of serotonin and thromboxane A 2 . 46 In an earlier study to address the role of NO in PSD, 26 the placement of L-NAME 0.1 g/L in the drinking water of rabbits did cause a blockade of acetylcholine-induced vasodilation, as measured by carotid resistance, but had no effect on the development of PSD. As the authors noted, however, L-NAME has been shown to be an antagonist of the cholinergic pathway. 41 It is possible that in these earlier experiments, the systemic blockade of NO production was not sufficient at the site of the stenosis to block hemodynamically released NO. A higher level of 0.5 g/L L-NAME in drinking water has been shown to attenuate vascular remodeling in rabbit carotid aorta in response to elevated flows created by an arteriovenous fistula. 47 With adventitial delivery or oral delivery of an L-arginine analogue, the exact level of the free agent within the target endothelium is not known. However, any nonlocal downstream effects of L-NAME diluted in the arterial flow (a concentration that we estimate by a steadystate wall diffusion/boundary layer flow model to be quite low) would be expected to be minimal, because systemic dosing with low-level L-NAME is insufficient to block PSD. 26 The experiments with indomethacin suggest that the attenuation of PSD by L-NAME or the other NO inhibitors was not due to a nonspecific inhibition of prostacyclin production. 38 Our observation that L-NNA (which does not inhibit the muscarinic receptor 41 ) significantly attenuated the development of PSD supports the role of NO as the mediator of PSD.
The induction of smooth muscle cell inducible NOS (iNOS) and release of NO (or peroxynitrite) by the altered mechanics of the stenosed vessel remain important avenues of investigation. Interestingly, the proximal region is exposed to greater distending forces due to pulsatile pressure and wave reflection, whereas the distal region experiences damped pulsatility due to the stenosis. In preliminary experiments, we have not detected elevated levels of iNOS antigen in the media of the vessel. Also, we observed that the distal PSD segments develop increased tone in response to phenylephrine and increased dilatory response to acetylcholine. In contrast, when iNOS is induced, 48, 49 rabbit vessels display decreased response to both phenylephrine and acetylcholine.
In addition, the persistent lack of smooth muscle cell contraction in the poststenotic region may make the noncellular structural elements of the vessel wall more susceptible to distension and circumferential stresses. It may be possible that excess NO (potentially via peroxynitrite) has a role in preaneurysmal processes such as the breakdown of the internal elastic lamina.
The results presented in this study also suggest that the 3-day stenosis model resulted in a functional change of vessel reactivity. An increased responsiveness of the PSD region to a receptor-mediated release of endothelial NO was observed. Similar findings have been observed in vessels exposed to chronic increases in blood flow and shear stress. 50 This is consistent with our calculations of increased shear stresses in the distal segment of the vessel. Miller and Burnett 50 found that both tonic and receptor-stimulated production of NO was enhanced in arterial blood vessels of the arteriovenous fistula canine model.
Although the hemodynamic origin of PSD is generally undisputed, the precise mechanisms have been controversial and the mediators unknown. The present study indicates that the major molecular mediator of PSD is NO, not prostacyclin. Further experimental and computational studies will help evaluate the hemodynamic regulation of NO and NO-derived species during the development of PSD. 
